Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.

Rationale for combination therapy with galantamine and memantine in Alzheimer's disease. J Clin Pharmacol. 2006 Jul; 46(7 Suppl 1):17S-26S.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.